InsidersTradesSigma
Total declarations
Companies
▲ Purchases (10 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Zakrzewski Joseph S. Officer active across 5 companies, notably Cyteir Therapeutics, Inc.. Cumulatively, 16 filings have been published. Total volume traded: €192k. The latest transaction was filed on 12 May 2022 — Acquisition. Regulator: SEC (Form 4). All data is free.
Declarations16 total
€1,152743 shares@ €1.55110.9% of flow
Common Stock
SEC:0001209191-22-029135:0·
Ideal exit: 6 Feb 2023 (T+270)
€88,65249,406 shares@ €1.794466.2% of flow
Common Stock
SEC:0001209191-22-028574:0·
Ideal exit: 4 Feb 2023 (T+270)
98,199 shares
Common Stock
SEC:0000899243-22-012992:0·
012,500 shares0
Common Stock
SEC:0001209191-22-014161:0·
€1,742200 shares@ €8.71227.9% of flow
Common Stock
SEC:0000899243-21-049973·
Ideal exit: 19 Sept 2022 (T+270)
€1,742200 shares@ €8.71221.3% of flow
Common Stock
SEC:0000899243-21-049973:0·
Ideal exit: 19 Sept 2022 (T+270)
€1,743200 shares@ €8.7177.9% of flow
Common Stock
SEC:0000899243-21-049198·
Ideal exit: 13 Sept 2022 (T+270)
€1,743200 shares@ €8.7171.3% of flow
Common Stock
SEC:0000899243-21-049198:0·
Ideal exit: 13 Sept 2022 (T+270)
€28,96610,000 shares@ €2.89660.0095% mcap100.0% of flow
Ordinary Shares
SEC:0001562180-21-007737·
Ideal exit: 10 Sept 2022 (T+270)
€28,96610,000 shares@ €2.89660.0095% mcap50.0% of flow
Ordinary Shares
SEC:0001562180-21-007737:0·
Ideal exit: 10 Sept 2022 (T+270)
€18,5952,000 shares@ €9.297484.2% of flow
Common Stock
SEC:0000899243-21-048432·
Ideal exit: 11 Sept 2022 (T+270)
€18,5952,000 shares@ €9.297413.9% of flow
Common Stock
SEC:0000899243-21-048432:0·
Ideal exit: 11 Sept 2022 (T+270)
34,499 shares
Common Stock
SEC:0001104659-21-142280·
34,499 shares
Common Stock
SEC:0001104659-21-142280:0·
58,671 shares
Common Stock
SEC:0000899243-21-025827·
58,671 shares
Common Stock
SEC:0000899243-21-025827:0·
16 of 16 declarations
About Zakrzewski Joseph S
Joseph S Zakrzewski is an executive at Cyteir Therapeutics, Inc.
